Keith W. Marshall

Insider Reports History

Entity
Individual
Location
C/O Conatus Pharmaceuticals Inc., 16745 West Bernardo Drive, Suite 200, San Diego, CA
Signature
/s/ Keith W. Marshall
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Keith W. Marshall:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Prometheus Biosciences, Inc. Chief Financial Officer Common Stock 0 $108.42 Jun 16, 2023 Direct
Prometheus Biosciences, Inc. Chief Financial Officer Stock Option (right to buy) 0 Jun 16, 2023 Direct

Insider Reports Filed by Keith W. Marshall

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RXDX Prometheus Biosciences, Inc. Jun 16, 2023 8 $0 4 Jun 16, 2023 Chief Financial Officer
RXDX Prometheus Biosciences, Inc. Jun 2, 2023 2 $242K 4 Jun 2, 2023 Chief Financial Officer
RXDX Prometheus Biosciences, Inc. Apr 5, 2023 3 -$1.05M 4 Apr 7, 2023 Chief Financial Officer
RXDX Prometheus Biosciences, Inc. Mar 6, 2023 3 -$1.18M 4 Mar 8, 2023 Chief Financial Officer
RXDX Prometheus Biosciences, Inc. Feb 15, 2023 3 -$578K 4 Feb 17, 2023 Chief Financial Officer
RXDX Prometheus Biosciences, Inc. Jan 17, 2023 3 -$577K 4 Jan 19, 2023 Chief Financial Officer
RXDX Prometheus Biosciences, Inc. Dec 16, 2022 1 $0 4 Dec 20, 2022 Chief Financial Officer
RXDX Prometheus Biosciences, Inc. Dec 9, 2022 2 $0 4 Dec 13, 2022 Chief Financial Officer
RXDX Prometheus Biosciences, Inc. May 20, 2022 1 $0 4 May 20, 2022 Chief Financial Officer
RXDX Prometheus Biosciences, Inc. Nov 14, 2021 1 $0 4 Nov 16, 2021 Chief Financial Officer